Related Experiment Video
Updated: Jun 20, 2026

Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section
Published on: July 19, 2016
CFD-driven optimization and experimental validation of venturi-based thrombectomy devices in a circle of willis
Iham F Zidane1, Xiaochen Wang2, Hainan He2
1Mechanical Engineering Department, College of Engineering and Technology, Arab Academy for Science, Technology and Maritime Transport, Alexandria, 1029, Egypt. iham_zidane@aast.edu.
None:
The geometry of the Circle of Willis poses major challenges for mechanical thrombectomy, where device navigability and effective thrombus removal determine treatment success. This study investigated the performance of venturi-inspired aspiration thrombectomy devices in a simplified cerebral artery segment representative of the middle cerebral artery (MCA), a frequent site of occlusion. Five designs (30°, 45°, 60° venturi, 7/11° taper, and cylindrical control) were assessed using a combined computational-experimental framework. On the computational side, unsteady Reynolds-averaged Navier-Stokes (URANS) simulations were performed in ANSYS Fluent 19.2 with k-ε turbulence closure. Blood-clot interactions were modeled using a Volume of Fluid (VOF) multiphase formulation with Carreau-Yasuda non-Newtonian rheology. In vitro, stereolithography-fabricated prototypes were tested with porcine thrombi in silicone arterial phantoms. CFD predicted extraction times of 2.12 s for the control and 1.64 s for the 45° venturi, with efficiency plateauing beyond 45°. Experimental results confirmed this trend, showing the 45° design as optimal and all venturi devices outperforming the control. Fragmentation analysis revealed a trade-off, with the 60° venturi producing more than twice the fragments of the 30°. These findings demonstrate that venturi taper geometry critically influences aspiration efficiency and fragmentation and establish CFD-experiment integration as a foundation for optimizing next-generation thrombectomy devices.

